Intriguingly, limited observations found that several important ICMs, such as PD-L1, B7-H4 and GAL-9, are also highly expressed in a subset of ICC cells, which suggests that although ICB-based immunotherapy may be effective against ICC, it has not been extensively studied so far [12]. This evidence concerns the gene LGALS9 and intrahepatic cholangiocarcinoma.